Graves disease

Changed by Alexandros Zarotis, 19 Apr 2019

Updates to Article Attributes

Body was changed:

Graves disease (in mainland Europe it is called Basedow disease 9) is an autoimmune thyroid disease and is the most common cause of thyrotoxicosis (up to 85%).

Epidemiology

There is a strong female predilection with an F:M ratio of at least 5:1. It typically presents in middle age.

Clinical presentation

Patients are thyrotoxic. Extrathyroid manifestations include:

The combination of exophthalmos, tachycardia, and goitre is called the Merseburger Triad.

Pathology

Results from an antibody directed stimulation of the thyroid-stimulating hormone (TSH) receptor, with resultant production and release of T3 and T4.

Macroscopic appearance

The affected gland shows diffuse, symmetrical enlargement, with a fleshy red cut surface. This appearance can be altered by preoperative treatment or chronicity.

Microscopic appearance

The histological features are consistent with the activated state of the gland:

  • plump follicular cells with increased amounts of eosinophilic cytoplasm
  • hyperplastic follicles with papillary epithelial infoldings
  • evidence of colloid reabsorption including 'scalloping' at the apical membrane and variable follicle collapse and exhaustion

These features can be altered by preoperative treatment or chronicity. 

Serology
  • TSH: suppressed
  • T4: elevated
  • T3: elevated
  • thyroid receptor antibodies (TSI, TGI, TBII): positive

Radiographic features

Ultrasound
  • thyroid gland is often enlarged and can be hyperechoic
  • heterogeneous thyroid echotexture
  • relative absence of nodularity in uncomplicated cases
  • hypervascular; may demonstrate a thyroid inferno pattern on colour Doppler 1
Nuclear medicine
  • 123I: imaging performed at around 2-6 days; classically demonstrates homogeneously increased activity in an enlarged gland
  • 99mTcpertechnetate: homogeneously increased activity in an enlarged thyroid gland

Differential diagnosis

For hyperthyroidism consider: 

History and etymology

It is named after Robert James Graves (1796-1852),Irish surgeon, who first described it in 1835 9, and Carl Adolph von BaselowBasedow (1799-1854), German physician, who described it in 1840 10,11. The Merseburger triad was first described by Dr BaselowBasedow who practiced in Merseburg 12.

Practical points

  • -</ul><h4>History and etymology</h4><p>It is named after <strong>Robert James Graves </strong>(1796-1852),<strong> </strong>Irish surgeon, who first described it in 1835 <sup>9</sup>, and <strong>Carl Adolph von Baselow</strong> (1799-1854), German physician, who described it in 1840 <sup>10,11</sup>. The Merseburger triad was first described by Dr Baselow who practiced in Merseburg <sup>12</sup>.</p><h4>Practical points</h4><ul><li>patients with Graves disease are at higher risk of <a href="/articles/iodinated-contrast-induced-thyrotoxicosis">iodinated contrast-induced thyrotoxicosis</a>
  • +</ul><h4>History and etymology</h4><p>It is named after <strong>Robert James Graves </strong>(1796-1852),<strong> </strong>Irish surgeon, who first described it in 1835 <sup>9</sup>, and <strong>Carl Adolph von Basedow</strong> (1799-1854), German physician, who described it in 1840 <sup>10,11</sup>. The Merseburger triad was first described by Dr Basedow who practiced in Merseburg <sup>12</sup>.</p><h4>Practical points</h4><ul><li>patients with Graves disease are at higher risk of <a href="/articles/iodinated-contrast-induced-thyrotoxicosis">iodinated contrast-induced thyrotoxicosis</a>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.